Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CarParts.com, Inc.PRTS · Entity 7113 | Director | May 19, 2026 | May 20, 2026 |
| TCW Special Purpose Acquisition Corp.TSPQ · Entity 122935 | Director | October 19, 2022 | October 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CarParts.com, Inc.
Report date May 19, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 186,717 |
Reported balance
After 2026-05-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 186,717 · Balance 186,717 F1: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the 2027 annual shareholder meeting date, as long as the Reporting Person's service with the Company has not previously ended. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the 2027 annual shareholder meeting date, as long as the Reporting Person's service with the Company has not previously ended.
TCW Special Purpose Acquisition Corp.
Report date October 19, 2022 · Filed October 25, 2022
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CarLotz, Inc.
Report date December 09, 2022 · Filed December 13, 2022
Section 16 reporting ended · disclosed 2022-12-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-12-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-12-09 · Disposition to issuer · Disposed 259,787 · Balance 0 F1: Disposed of in accordance with the terms of the Agreement and Plan of Merger, dated as of August 9, 2022 (the "Merger Agreement"), by and among the Issuer, Shift Technologies, Inc. ("Shift") and Shift Remarketing Operations, Inc. ("Merger Sub"), pursuant to which, on December 9, 2022 (the "Effective Time"), among other things, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Shift (the "Merger"). F2: (Continued from Footnote 1) In accordance with the terms of the Merger Agreement, at the Effective Time of the Merger, each issued and outstanding share of Class A Common Stock of the Issuer (other than shares of Issuer Common Stock held in treasury by the Issuer and not on behalf of a third party) (the "CarLotz Common Stock") was converted automatically into the right to receive 0.705241 (the "Exchange Ratio") of a duly authorized, validly issued, fully paid and nonassessable share of Class A common stock of Shift (the "Shift Common Stock"), rounded up to the nearest whole share for any fractional share of Shift Common Stock that would be issued to any holder of CarLotz Common Stock after aggregating all fractional shares of Shift Common Stock that would otherwise be received by such holder resulting from the calculation. F3: At the Effective Time, each time-based restricted stock unit (excluding Company Earnout Acquiror RSUs (as defined in the Merger Agreement)) ("RSU") that was outstanding immediately prior to the Effective Time and to the extent vested at the Effective Time pursuant to its terms, was cancelled and converted into the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio, less applicable tax withholding. Each other RSU was assumed by Shift and converted into an equivalent RSU denominated in Shift Common Stock representing the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio. F4: These restricted stock units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in accordance with the terms of the Agreement and Plan of Merger, dated as of August 9, 2022 (the "Merger Agreement"), by and among the Issuer, Shift Technologies, Inc. ("Shift") and Shift Remarketing Operations, Inc. ("Merger Sub"), pursuant to which, on December 9, 2022 (the "Effective Time"), among other things, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Shift (the "Merger").
F2: (Continued from Footnote 1) In accordance with the terms of the Merger Agreement, at the Effective Time of the Merger, each issued and outstanding share of Class A Common Stock of the Issuer (other than shares of Issuer Common Stock held in treasury by the Issuer and not on behalf of a third party) (the "CarLotz Common Stock") was converted automatically into the right to receive 0.705241 (the "Exchange Ratio") of a duly authorized, validly issued, fully paid and nonassessable share of Class A common stock of Shift (the "Shift Common Stock"), rounded up to the nearest whole share for any fractional share of Shift Common Stock that would be issued to any holder of CarLotz Common Stock after aggregating all fractional shares of Shift Common Stock that would otherwise be received by such holder resulting from the calculation.
F3: At the Effective Time, each time-based restricted stock unit (excluding Company Earnout Acquiror RSUs (as defined in the Merger Agreement)) ("RSU") that was outstanding immediately prior to the Effective Time and to the extent vested at the Effective Time pursuant to its terms, was cancelled and converted into the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio, less applicable tax withholding. Each other RSU was assumed by Shift and converted into an equivalent RSU denominated in Shift Common Stock representing the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio.
F4: These restricted stock units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant.
Kindred Biosciences, Inc.
Report date August 27, 2021 · Filed August 30, 2021
Section 16 reporting ended · disclosed 2021-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.08 · Expires 2031-02-04 | Direct | 0 |
Reported balance
After 2021-08-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-08-27 · Disposition to issuer · Disposed 48,000 · Balance 0 F1: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement"), the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $200,160.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement"), the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $200,160.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 20, 2026 00:28 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantRestricted Stock Units · Derivative | 186,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001378950-26-000064 · form4.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,717 Underlying: Common Stock · 186,717 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the 2027 annual shareholder meeting date, as long as the Reporting Person's service with the Company has not previously ended. F1 · derivative.exercise_date: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the 2027 annual shareholder meeting date, as long as the Reporting Person's service with the Company has not previously ended. F1 · derivative.expiration_date: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the 2027 annual shareholder meeting date, as long as the Reporting Person's service with the Company has not previously ended. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 21:56 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantRestricted Stock Units · Derivative | 182,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001378950-25-000077 · form4.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,222 Underlying: Common Stock · 182,222 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the date when the Reporting Person finishes a 12-month service period from the grant date. F1 · derivative.exercise_date: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the date when the Reporting Person finishes a 12-month service period from the grant date. F1 · derivative.expiration_date: Reflects cash-settled RSUs. Each RSU represents a contingent right to receive an amount in cash equal to the fair market value of one share of the Issuer's common stock on the applicable vesting date. The RSUs shall vest on the date when the Reporting Person finishes a 12-month service period from the grant date. Read SEC document |
| May 23, 2024 Filed May 29, 2024 00:39 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantCommon Stock | 32,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001378950-24-000074 · form4.xml · nonDerivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,551 F1 · kind: Granted pursuant to the CarParts.com, Inc. 2016 Equity Incentive Plan, these restricted stock units shall vest in full at the Company's 2025 annual stockholder meeting. Read SEC document |
| May 25, 2023 Filed May 31, 2023 00:00 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001378950-23-000044 · form4.xml · nonDerivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,751 F1 · kind: Granted pursuant to the CarParts.com, Inc. 2016 Equity Incentive Plan, these restricted stock units shall vest in full at the Company's 2024 annual stockholder meeting. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 02:42 UTC | CarLotz, Inc. LOTZ · Entity 121687 | Disposition to issuerRestricted Stock Units · Derivative | 259,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-079260 · ownership.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 259,787 shares Expires not disclosed F1 · derivative.exercise_price: Disposed of in accordance with the terms of the Agreement and Plan of Merger, dated as of August 9, 2022 (the "Merger Agreement"), by and among the Issuer, Shift Technologies, Inc. ("Shift") and Shift Remarketing Operations, Inc. ("Merger Sub"), pursuant to which, on December 9, 2022 (the "Effective Time"), among other things, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Shift (the "Merger"). F2 · derivative.exercise_price: (Continued from Footnote 1) In accordance with the terms of the Merger Agreement, at the Effective Time of the Merger, each issued and outstanding share of Class A Common Stock of the Issuer (other than shares of Issuer Common Stock held in treasury by the Issuer and not on behalf of a third party) (the "CarLotz Common Stock") was converted automatically into the right to receive 0.705241 (the "Exchange Ratio") of a duly authorized, validly issued, fully paid and nonassessable share of Class A common stock of Shift (the "Shift Common Stock"), rounded up to the nearest whole share for any fractional share of Shift Common Stock that would be issued to any holder of CarLotz Common Stock after aggregating all fractional shares of Shift Common Stock that would otherwise be received by such holder resulting from the calculation. F3 · derivative.exercise_price: At the Effective Time, each time-based restricted stock unit (excluding Company Earnout Acquiror RSUs (as defined in the Merger Agreement)) ("RSU") that was outstanding immediately prior to the Effective Time and to the extent vested at the Effective Time pursuant to its terms, was cancelled and converted into the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio, less applicable tax withholding. Each other RSU was assumed by Shift and converted into an equivalent RSU denominated in Shift Common Stock representing the right to receive a number of shares of Shift Common Stock equal to the product of (i) the number of vested whole shares of CarLotz Common Stock subject to such award immediately prior to the Effective Time and (ii) the Exchange Ratio. F4 · derivative.exercise_date: These restricted stock units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. F4 · derivative.expiration_date: These restricted stock units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:11 UTC | CarLotz, Inc. LOTZ · Entity 121687 | GrantRestricted Stock Units · Derivative | 259,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-077696 · tm220554d2_4.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,787 Underlying: Class A Common Stock · 259,787 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: These Restricted Stock Units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. F2 · derivative.expiration_date: These Restricted Stock Units vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:41 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantCommon Stock | 23,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011865 · doc1.xml · nonDerivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,751 F1 · kind: Granted pursuant to the CarParts.com, Inc. 2016 Equity Incentive Plan, these restricted stock units shall vest in full at the Company's 2023 annual stockholder meeting. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 18:35 UTC | Kindred Biosciences, Inc. KIN · Entity 135544 | Disposition to issuerStock Option (right to buy) · Derivative | 48,000 | $4.17 Strike: $5.08 | $200,160.00 |
DisclosureSEC source: 0001250853-21-000083 · primary_doc.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,000 shares Expires 2031-02-04 F1 · price: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement"), the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $200,160.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. F1 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement"), the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $200,160.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:47 UTC | CarParts.com, Inc. PRTS · Entity 7113 | GrantCommon Stock | 10,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-010840 · doc1.xml · nonDerivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,441 F1 · kind: Granted pursuant to the CarParts.com, Inc. 2016 Equity Incentive Plan, these restricted stock units shall vest in full at the Company's 2022 annual stockholder meeting. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 22:58 UTC Amendment | Kindred Biosciences, Inc. KIN · Entity 135544 | GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001250853-21-000031 · primary_doc.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: The option will vest in four equal quarterly installments from the option grant date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 19:06 UTC | Kindred Biosciences, Inc. KIN · Entity 135544 | GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001250853-21-000029 · primary_doc.xml · derivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: The option will vest in four equal quarterly installments from the option grant date. Read SEC document |
| August 20, 2020 Filed Aug 20, 2020 21:55 UTC | CarParts.com, Inc. PRTS · Entity 7113 | PurchaseCommon Stock | 730 | $15.05 | $10,986.50 |
DisclosureSEC source: 0001567619-20-015845 · doc1.xml · nonDerivative · entry 2 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 F2 · price: The price reported above reflects the weighted-average buy price. The open market purchases were at prices ranging from $15.02 to $15.09. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:55 UTC | CarParts.com, Inc. PRTS · Entity 7113 | PurchaseCommon Stock | 320 | $14.70 | $4,704.00 |
DisclosureSEC source: 0001567619-20-015845 · doc1.xml · nonDerivative · entry 1 Liu Nanxi · CIK 0001818497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320 F1 · price: The price reported above reflects the weighted-average buy price. The open market purchases were all at a price of $14.70. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.